Mechanistic Model of Rothia mucilaginosa Adaptation toward Persistence in the CF Lung, Based on a Genome Reconstructed from Metagenomic Data

Механистическая модель адаптации Rothia mucilaginosa к персистенции в легких при муковисцидозе на основе генома, реконструированного из метагеномных данных
Robert A. Edwards, Douglas Conrad, Forest Rohwer, Katrine Whiteson, Mike Furlan, David A. Low, Christopher S. Hayes, Robert Schmieder, Matthew Haynes, Stephen J. Poole, Yan Wei Lim, T. David Matthews, Heather Maughan
2013-05-30

Rothia mucilaginosaantibiotic resistancecystic fibrosis lungextracellular lactate utilizationmetagenomic genome reconstruction
The impaired mucociliary clearance in individuals with Cystic Fibrosis (CF) enables opportunistic pathogens to colonize CF lungs. Here we show that Rothia mucilaginosa is a common CF opportunist that was present in 83% of our patient cohort, almost as prevalent as Pseudomonas aeruginosa (89%). Sequencing of lung microbial metagenomes identified unique R. mucilaginosa strains in each patient, presumably due to evolution within the lung. The de novo assembly of a near-complete R. mucilaginosa (CF1E) genome illuminated a number of potential physiological adaptations to the CF lung, including antibiotic resistance, utilization of extracellular lactate, and modification of the type I restriction-modification system. Metabolic characteristics predicted from the metagenomes suggested R. mucilaginosa have adapted to live within the microaerophilic surface of the mucus layer in CF lungs. The results also highlight the remarkable evolutionary and ecological similarities of many CF pathogens; further examination of these similarities has the potential to guide patient care and treatment.
1
A near-complete de novo assembled R. mucilaginosa (CF1E) genome indicates adaptations including antibiotic resistance.
2
Metagenome-predicted metabolic traits suggest R. mucilaginosa is adapted to live in the microaerophilic surface of the CF mucus layer.
3
Modification of the type I restriction-modification system was identified in the CF1E genome as a possible adaptation.
4
R. mucilaginosa shares remarkable evolutionary and ecological similarities with many other CF pathogens, with implications for guiding patient care and treatment.
5
Rothia mucilaginosa is a common CF lung opportunist, present in 83% of the patient cohort, nearly as prevalent as Pseudomonas aeruginosa (89%).
6
Sequencing of lung metagenomes revealed unique R. mucilaginosa strains in each patient, suggesting within-lung evolution.
7
The CF1E genome shows potential for utilization of extracellular lactate as a metabolic adaptation to the CF lung.

Rothia mucilaginosa populations/strain(s) colonizing cystic fibrosis (CF) lungs (genome CF1E reconstructed from metagenomic data)

Mechanistic physiological and genomic adaptations enabling persistence in the CF lung, including antibiotic resistance, extracellular lactate utilization, type I restriction–modification system modification, and adaptation to a microaerophilic mucus-layer niche

Publication Details
Publication Date
2013-05-30
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Robert A. Edwards
Douglas Conrad
Forest Rohwer
Katrine Whiteson
Mike Furlan
David A. Low
Christopher S. Hayes
Robert Schmieder
Matthew Haynes
Stephen J. Poole
Yan Wei Lim
T. David Matthews
Heather Maughan
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%